ACON Labs. FDA EUA authorized
Flowflex™ COVID-19 Antigen Home Test
SAN DIEGO, CA., June 2022 – ACON Laboratories, Inc., a leading global medical device manufacturer for 25 years, manufactures the Flowflex™ COVID-19 Antigen Home Test which was authorized for emergency use in October 2021 by the U.S. Food and Drug Administration.
- The Flowflex COVID-19 Home Test small packaging is easy for consumers to travel with, retailers to display, and distributors to warehouse.
- The 16-month shelf-life lessens inventory turnover stress.
- Wide storage temperature range (36 - 86 °F) allows for savings on shipping and warehousing costs.
Non-refrigerated shipping and warehousing.
- The required nasal sample can be self-collected by individuals 14 years and older, or adult-collected from children as young as 2 years old.
- Clear results in 15 minutes, convenient testing without waiting for lab results.
- 93% accurate, one of the highest accuracy ratings among rapid antigen home tests.
- The small size of the sterile swab makes collecting the nasal sample less intimidating to children.
- The kit box includes a test cassette, an extraction buffer tube, an integrated tube holder, a sterile nasal swab, and instructions in English and Spanish.
- Free Web Application for results recording and step-by-step instructions.
The popularity of the Flowflex COVID-19 Antigen Home Test has led ACON to greatly expand its manufacturing production capacity. This emergency use authorization has allowed ACON to quickly respond to the unmet demand for simple and inexpensive home diagnostics as a critical tool in the fight against COVID-19.